Mapping and ablation to treat abnormal heart electrical signals
Part of Genetic & congenital, Heart & circulation clinical trials.
This study uses detailed 3D heart mapping to find where abnormal electrical activity starts in Brugada syndrome and then performs ablation (a targeted scar or block). It’s mainly for adults who have had concerning symptoms and already have an implanted defibrillator (ICD).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult who can sign informed consent in writing
- You have Brugada-pattern heart ECG changes (types 1 and 2), seen on your own or after an Ajmaline test
- In the last 12 months, you’ve had documented episodes of fast/chaotic heart rhythm (VT/VF)
- You already have an ICD implanted
- You are a candidate for ablation using a 3D mapping system (based on your doctors’ decision and standard guidance)
- You have not had a heart ablation in the past 90 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way of mapping damaged heart muscle to improve the precision of a procedure called catheter ablation, which treats dangerously fast heart rhythms. It may help people with heart disease who need this procedure.
This trial tests a new heart-mapping technique to help doctors treat a fast heart rhythm caused by heart disease. It might improve the precision of the procedure, making it safer and more effective for patients with this condition.
This trial tests two different ways of mapping the heart to guide treatment for a dangerous fast heart rhythm. The goal is to see which mapping method works better for people with an ICD who need a procedure called ablation to stop the rhythm.
This study looks for hidden heart rhythm problems in adults. It involves simple tests to find conditions that might otherwise go unnoticed.
This trial tests a special catheter to map abnormal heart rhythms like ventricular tachycardia or atrial fibrillation. It may help patients who need a procedure to find and treat the source of these fast or irregular heartbeats.
This trial tests a new approach to treating a dangerous heart rhythm called ventricular tachycardia (VT) in people with scarred heart muscle. The goal is to use only the scarred area to guide the ablation procedure, which may make it safer and more effective.
Hear when a new Brugada Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.